Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

NCT01193127 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: OMS302 Solution
DRUG: OMS302 Mydriatic Solution
DRUG: OMS302 Anti-inflammatory Solution
DRUG: Balanced Salt Solution (BSS) Solution

Sponsor

Omeros Corporation